The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Compass Therapeutics Inc’s current trading price is -18.14% away from its 52-week high, while its distance from the 52-week low is 212.15%. The stock’s price range for this period has been between $1.07 and $4.08 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.93 million for the day, a number notably higher than the average daily volume of 0.83 million over the last three months.
The stock price for Compass Therapeutics Inc (CMPX) currently stands at $3.34. The stock experienced a substantial increase in the last session, hitting $32.0 after starting at $3.34. The stock’s lowest price was $7.0 before closing at $2.7.
Compass Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $4.08 on 02/11/25 and a low of $1.07 for the same time frame on 08/12/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Compass Therapeutics Inc (CMPX) has experienced a quarterly rise of 83.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 461.86M and boasts a workforce of 35 employees.
Compass Therapeutics Inc: What Analysts Are Saying
As of right now, 7 analysts are rating Compass Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.33, with a change in price of +1.03. Similarly, Compass Therapeutics Inc recorded 1,213,661 in trading volume during the last 100 days, posting a change of +44.59%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CMPX stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.
CMPX Stock Stochastic Average
Compass Therapeutics Inc’s raw stochastic average for the past 50 days is presently 92.09%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 86.08%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 36.31% and 28.14%, respectively.
CMPX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 271.11%. However, over the past six months, we’ve seen a stronger performance of -4.57%. The price of CMPX fallen by 23.70% over the last 30 days. And in the last five days, it has surged by 17.19%.
